|
Originally published In Press as doi:10.1074/jbc.M003132200 on August 16, 2000
J. Biol. Chem., Vol. 275, Issue 44, 34766-34771, November 3, 2000
Ca2+-dependent Regulation of the Motor
Activity of Myosin V*
Kazuaki
Homma,
Junya
Saito,
Reiko
Ikebe, and
Mitsuo
Ikebe
From the Department of Physiology, University of Massachusetts
Medical School, Worcester, Massachusetts 01655-0127
Received for publication, April 12, 2000, and in revised form, July 18, 2000
 |
ABSTRACT |
Mouse myosin V constructs were produced that
consisted of the myosin motor domain plus either one IQ motif (M5IQ1),
two IQ motifs (M5IQ2), a complete set of six IQ motifs (SHM5), or the complete IQ motifs plus the coiled-coil domain (thus permitting formation of a double-headed structure, DHM5) and expressed in Sf9 cells. The actin-activated ATPase activity of all constructs except M5IQ1 was inhibited above pCa 5, but this inhibition
was completely reversed by addition of exogenous calmodulin. At the same Ca2+ concentration, 2 mol of calmodulin from SHM5 and
DHM5 or 1 mol of calmodulin from M5IQ2 were dissociated, suggesting
that the inhibition of the ATPase activity is due to dissociation of
calmodulin from the heavy chain. However, the motility activity of DHM5
and M5IQ2 was completely inhibited at pCa 6, where no
dissociation of calmodulin was detected. Inhibition of the motility
activity was not reversed by the addition of exogenous calmodulin.
These results indicate that inhibition of the motility is due to
conformational changes of calmodulin upon the Ca2+ binding
to the high affinity site but is not due to dissociation of calmodulin
from the heavy chain.
 |
INTRODUCTION |
Myosins are motor proteins that translocate actin filaments upon
hydrolysis of ATP, and thus they play a critical role in diverse forms
of cell contractility and motility. During the last decade a number of
myosin-like proteins have been found, and the myosins are currently
organized into 15 classes based upon phylogenetic sequence comparisons
of the motor domains (1-5). Class V myosin was originally identified
in brain as a calmodulin-binding protein that had
actin-dependent ATPase activity (6). Myosin V is a member
of the myosin superfamily that is expressed in variety of cell types
and is involved in a variety of membrane trafficking and organelle
transport functions (1-5). Myosin V has two heads that are connected
with a long coiled-coil domain; however, in contrast to conventional
myosin, it contains a globular C-terminal domain and does not form
thick filaments (7). The head domain is composed of a globular motor
domain and an elongated neck domain that is associated with a number of
light chains. The sequence at the neck region contains six IQ motifs
that have been implicated as calmodulin or myosin light chain binding
consensus motifs as found in a variety of calmodulin-binding proteins
and myosins (7). Since light chains play a critical role in the
regulation of various conventional myosins, it has been proposed that
the IQ domain serves as a regulatory component of myosin V. The role of
the IQ motif and bound calmodulin serving as a regulatory component of
unconventional myosins is best studied for mammalian myosin Is. For
both brush border myosin I (8-10) and myosin I (11-13), high
Ca2+ inhibits motor activity due to Ca2+
binding to the calmodulin light chain. Since 1 mol of bound calmodulin dissociates from myosin I at high Ca2+, it was originally
thought that this dissociation of calmodulin was responsible for the
inhibition of myosin I motor activity. However, since virtually no
calmodulin dissociation is observed at pCa 6 where the
motility activity is completely abolished, this view has been
questioned (13). For naturally isolated myosin V, motility activity is
inhibited at high Ca2+, whereas actin-activated ATPase
activity markedly increases in the presence of Ca2+ (7).
Recently it was shown (14) that a truncated recombinant monomeric
myosin V with two IQ motifs had motility activity that was inhibited at
high Ca2+, but only in the absence of exogenous calmodulin,
suggesting that the inhibition is via the physical dissociation of
calmodulin. Interestingly, the truncated myosin V showed inhibition of
actin-activated ATPase activity by Ca2+ rather than
activation, as is found for naturally isolated myosin V (14). This
apparent discrepancy is not understood, but there are several possible
explanations. Since the two-headed structure is critical for the
regulation of both conventional smooth muscle and non-muscle myosin
motor function, it is plausible that the two-headed structure may play
some role in the regulatory mechanisms of myosin V. Alternatively, a
complete neck domain may be required for the proper regulation of
myosin V.
The aim of the present study is to clarify the regulation of myosin V
motor function by Ca2+. To address these questions, we have
produced a two-headed myosin V construct, a single-headed construct
having the entire neck domain (six IQ motifs), and a truncated
single-headed construct containing only two IQ motifs. These myosin V
constructs were expressed, purified, and examined for motor function.
It was found that although calmodulin dissociation is responsible for
inhibition of actin-activated ATPase activity at high Ca2+,
inhibition of motility occurs at lower Ca2+ where
calmodulin is not dissociated from myosin V heavy chain.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction enzymes and modifying enzymes were
purchased from New England Biolabs (Beverly, MA). Actin was prepared
from rabbit skeletal muscle acetone powder according to Spudich and
Watt (15). Recombinant calmodulin from Xenopus oocyte (16)
was expressed in Escherichia coli as described (17).
Generation of the Expression Vectors for Myosin V Mutants--
A
baculovirus transfer vector for mouse myosin V variants in pBluebac4
(Invitrogen, CA) was produced as follows. Mouse myosin V cDNA
clones containing 35-1549 and 1549-3928 in pBluescript were kindly
supplied by Dr. N. Jenkins (NCI, National Institutes of Health). A
cDNA fragment-(1549-3928) flanked with EcoRI
sites was ligated to the vector containing a cDNA
fragment-( 35-1549) at the unique EcoRI site at nucleotide
1549. A unique NheI site was created at the 5' side of the
initiation codon; a unique KpnI site at nucleotide 2125 was
deleted without changing the resulting amino acid residue, and a new
KpnI site was created at nucleotide 3578. A cDNA
fragment was excised with NheI/KpnI digestion and in-frame ligated to a PBluebac4His baculovirus transfer vector containing a hexahistidine tag sequence with a stop codon at the 3'
side of the KpnI site. This construct (DHM5), containing the entire coiled-coil domain, was used to express double-headed myosin V. To obtain single-headed myosin V with complete IQ motifs, a KpnI site was created at nucleotide 2744 of DHM5. The vector
was digested with KpnI and the nucleotide
fragment-(2744-3578) was removed. The vector was self-ligated and used
as a construct expressing a single-headed myosin V with complete IQ
motifs (SHM5). A KpnI site was also created at nucleotide
2468 or 2393 of DHM5. Vectors containing nucleotides 1-2468 and
1-2393 of myosin V were used to express single-headed myosin V that
contained two IQ motifs (M5IQ2) and one IQ motif (M5IQ1), respectively.
For M5IQ2, nucleotides encoding a Myc tag sequence (EQKLISEEDL) were
inserted at 5' side of the hexahistidine tag.
Preparation of Recombinant Myosin V--
To express recombinant
myosin V, 200 ml of Sf9 cells (about 1 × 109)
were coinfected with two separate viruses expressing the myosin V heavy
chain and calmodulin, respectively. The cells were cultured at 28 °C
in 175-cm2 flasks and harvested after 3 days. Cells were
lysed with sonication in 30 ml of Lysis Buffer (0.15 M
NaCl, 30 mM KPi, pH 8.0, 5 mM MgCl2, 2 mM -mercaptoethanol, 2 mM phenylmethanesulfonyl fluoride, 0.2 mM
N-p-tosyl-L-phenylalanine
chloromethyl ketone, 0.2 mM
N-p-tosyl-L-lysine chloromethyl
ketone, 0.01 mg/ml leupeptin, 0.1 mg/ml trypsin inhibitor, 10%
glycerol, and 2 mM ATP). After centrifugation at
140,000 × g for 15 min, the supernatant was incubated
with 50 mM glucose and 20 units/ml hexokinase at 4 °C
for 30 min to hydrolyze completely residual ATP. F-actin (0.2 mg/ml)
was added to the sample and centrifuged (140,000 × g
for 20 min) to coprecipitate the expressed myosin V. The pellets were
washed once with buffer A (0.3 M NaCl, 30 mM
KPi, pH 8.0, 0.1 mM EGTA, 10 mM
-mercaptoethanol) and then resuspended with buffer A with 5 mM MgCl2 and 5 mM ATP to release myosin V from F-actin. The supernatant was mixed with 0.2 ml of nickel-nitrilotriacetic acid-agarose (Qiagen, Hilden, Germany) in a
50-ml conical tube on a rotating wheel for 30 min at 4 °C. The resin
suspension was then loaded on a column (1 × 10 cm) and was washed
with 10-fold volume of buffer B (0.3 M KCl, 20 mM imidazole, pH 7.5, 0.1 mM EGTA, and 10 mM -mercaptoethanol). Myosin V was eluted with buffer C
(0.1 M KCl, 0.1 mM EGTA, 10 mM
-mercaptoethanol, and 0.2 M imidazole, pH 7.5).
After SDS-polyacrylamide gel electrophoresis analysis, fractions
containing myosin V were pooled and dialyzed against 150 mM
KCl, 20 mM MOPS,1
pH 7.0, and 1 mM dithiothreitol. The purified myosin V was
stored on ice and used within 2 days. Typically, 1 mg of isolated
myosin V was obtained.
Gel Electrophoresis and ATPase Assay--
SDS-polyacrylamide gel
electrophoresis was carried out on a 7.5-20% polyacrylamide gradient
slab gel using the discontinuous buffer system of Laemmli (18).
Molecular mass markers used were smooth muscle myosin heavy chain (204 kDa), -galactosidase (116 kDa), phosphorylase b (97.4 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), carbonic
anhydrase (29 kDa), myosin regulatory light chain (20 kDa), and
-lactalbumin (14.2 kDa). The amount of the myosin V heavy chain and
calmodulin was determined by densitometry as described previously (13).
The steady-state ATPase activity was determined by measuring liberated
Pi at 25 °C as described previously (19).
In Vitro Motility Assay--
The in vitro motility
assay was performed as described previously (20). Myosin V was attached
to the coverslip. For M5IQ2, a coverslip was first coated with anti-Myc
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), and then the
surface of the coverslip was blocked with bovine serum albumin. Myosin
V was then applied to the coverslip. Actin filament velocity was
calculated from the movement distance and the elapsed time in
successive snapshots. Student's t test was used for
statistical comparison of mean values. A value of p < 0.01 was considered to be significant.
 |
RESULTS |
Expression of Myosin V Constructs--
In order to study the
regulatory mechanism of myosin V motor function, various myosin V
constructs were produced and expressed in Sf9 insect cells. The
DHM5 construct contains the entire coiled-coil domain in addition to
the complete head domain, so it is anticipated that it has a
double-headed structure (Fig. 1). SHM5
has an entire head domain with complete IQ motifs but no coiled-coil
domain, thus it is expected to be a single-headed molecule (Fig. 1). On the other hand, M5IQ2 contains a motor domain but only 2 N-terminal IQ
motifs out of the six IQ motifs typically present. All constructs contain hexahistidine tags to aid in purification. The histidine tags
were introduced at the C-terminal end of the molecule rather than its
N-terminal end to avoid possible misfolding of the protein and any
effects on motor function. Addition of a hexahistidine tag at the
C-terminal end of myosins has been performed with conventional (21) as
well as unconventional
myosin,2 and no influence on
motor function was observed. The cells were coinfected with myosin
V-expressing virus and calmodulin-expressing virus. The ratio of the
two viruses to achieve the best myosin V expression was empirically
determined. It should be noted that myosin V with bound calmodulin can
be obtained without the coinfection of calmodulin-expressing virus but
that the fraction of soluble myosin V increases significantly with
calmodulin coexpression. This tendency was more prominent for
constructs having an entire IQ domain. Fig.
2 shows SDS-polyacrylamide gel
electrophoresis of the purified constructs. Each myosin V construct was
composed of a high molecular mass band and a low molecular mass band.
The molecular mass of each slow mobility band was consistent with the
calculated molecular mass of each myosin construct, i.e.
130, 100, and 90 kDa for DHM5, SHM5, and M5IQ2, respectively. These bands were recognized by anti-His antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) indicating that these high molecular mass bands are the
expressed myosin V heavy chains (not shown). The small subunits showed
a mobility shift with a change in [Ca2+] that is
characteristic of calmodulin, suggesting that the small subunits are
indeed calmodulin. The identification of the small subunit was also
confirmed using anti-calmodulin antibodies (not shown). The
stoichiometries of calmodulin versus myosin V heavy chain
for DHM5, SHM5, and M5IQ2 were 5.7 ± 0.7, 5.3 ± 0.7, and 2.1 ± 0.5, respectively. This is consistent with the number of IQ
motifs in each construct.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic drawing of myosin V
constructs. The motor domain of myosin V is indicated by the
filled black ovals. Calmodulin light chains are indicated by
dotted shapes. The coiled-coil domain is indicated by a
chain figure.
|
|

View larger version (137K):
[in this window]
[in a new window]
|
Fig. 2.
SDS-polyacrylamide gel of purified myosin V
constructs. Molecular masses are indicated to the left.
Apparent molecular mass of each myosin V construct was consistent with
the expected molecular mass calculated by the amino acid numbers of
each construct. Low molecular mass band shifts its mobility by
Ca2+. Lanes 1, 4, and 7 are molecular
mass standards. Lanes 2, 5, and 8 are in 1 mM Ca2+, and lanes 3, 6, and
9 are in 1 mM EGTA. Lanes 2 and
3, DHM5; lanes 5 and 6, SHM5;
lanes 8 and 9, M5IQ2.
|
|
Actin-activated ATPase Activity--
The actin-activated ATPase
activity was measured as a function of free Ca2+ (Fig.
3). For most constructs, i.e.
DHM5, SHM5, and M5IQ2, the ATPase activity decreased markedly above
pCa 6. In contrast, M5IQ1 showed no pCa
dependence (not shown). Interestingly, inhibition of ATPase activity
was reversed by addition of 12 µM calmodulin in assay
solution (Fig. 3). The effect of exogenous calmodulin on the ATPase
activity was common for all three constructs. Fig. 4 shows the calmodulin concentration
dependence of the actin-activated ATPase activity of the myosin V
constructs. The calmodulin dependence on the activation of the ATPase
activity for the three constructs was similar, and a half-maximal
activation was observed at 10 6 M
calmodulin concentration. There was no difference in calmodulin dependence of ATPase activity between pCa 5 and 4, suggesting that the Ca2+ effect is saturated at
pCa 5. Fig. 5 shows the
F-actin dependence of the actin-activated ATPase activities of the
three constructs. The actin concentration dependence was similar to
each other for the three constructs. Kactin
estimated from the actin dependence of the ATPase activity was 0.95, 0.80, and 0.60 µM for DHM5, SHM5 and M5IQ2, respectively,
in the presence of EGTA. On the other hand, the actin concentration
dependence at high [Ca2+] showed two phases. At low
F-actin concentration, activity increased with actin concentration, and
it was not dramatically different from that in the presence of EGTA.
However, the activity decreased at higher actin concentrations. This
result suggests that the Ca2+-dependent
inhibition of ATPase activity is not due to a change in the affinity
for F-actin. The binding of myosin V constructs to F-actin was examined
by cosedimentation analysis in the presence of Mg2+-ATP to
test further the effect of Ca2+ on the affinity between
myosin V and F-actin. For all three constructs a significant amount of
myosin V cosedimented with F-actin at low ionic strength (more than
50%), but no significant effect of Ca2+ on the binding was
observed (not shown). The difference in F-actin dependence of the
ATPase activities of myosin V at high and low Ca2+
conditions is discussed under "Discussion."

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Actin-activated ATPase activity of myosin V
constructs as a function of free Ca2+. The
actin-activated ATPase activity of myosin V constructs (2 µg/ml) was
measured in the buffer containing 30 mM KCl, 1 mM MgCl2, 0.5 mg/ml actin, 0.2 mM
[ -32P]ATP, and 20 mM MOPS, pH 7.0, in the
presence ( ) and absence ( ) of 12 µM exogenous
calmodulin at 25 °C. The activity is indicated per head of myosin V. A, DHM5; B, SHM5; C, M5IQ2.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 4.
Activation of the actin-activated ATPase
activity of myosin V constructs by calmodulin. The actin-activated
ATPase activity of myosin V constructs was measured as a function of
exogenous calmodulin concentration. The conditions of the assay were
the same as described in Fig. 3. A, DHM5; B,
SHM5; C, M5IQ2. , pCa 5; , pCa
4.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
F-actin dependence of the actin-activated
ATPase activity of myosin V constructs. The actin-activated ATPase
activity of myosin V constructs was measured as described in Fig. 3. No
exogenous calmodulin was added. A, DHM5; B, SHM5;
C, M5IQ2. , EGTA; , pCa 4.
|
|
Dissociation of Calmodulin from Myosin V--
The reversal of the
ATPase activity inhibition by high concentrations of exogenous
calmodulin suggests that it is due to a decrease in the affinity of
calmodulin for myosin V when calmodulin binds Ca2+. To
address this notion, the dissociation of calmodulin from myosin V was
examined. Myosin V constructs were mixed with F-actin in various free
Ca2+ concentrations and then ultracentrifuged to determine
bound calmodulin. F-actin coprecipitated myosin V with bound calmodulin
was analyzed by SDS-polyacrylamide gel electrophoresis, and the
calmodulin band was quantitated by densitometry normalized with myosin
V heavy chain. As a control free calmodulin was centrifuged with F-actin, but no calmodulin coprecipitation was detected. Myosin V
constructs were also tested for precipitation, but no myosin V was
precipitated in the absence of F-actin. As shown in Fig. 6, the calmodulin bound to myosin V
decreased significantly between pCa 6 and 5 for all three
constructs. Approximately 55% of bound calmodulin was dissociated from
M5IQ2 heavy chain, indicating that 1 mol of calmodulin is dissociated
from M5IQ2. On the other hand, approximately 35% of the bound
calmodulin was dissociated from the DHM5 and SHM5 constructs,
indicating that 2 mol of bound calmodulin out of 6 total are
dissociated.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Dissociation of bound calmodulin from myosin
V constructs at high Ca2+. Molar ratio of calmodulin
to myosin V heavy chain under different pCa conditions is
determined as described under "Experimental Procedures." , DHM5;
, SHM5; , M5IQ2.
|
|
Effect of Ca2+ on the Motility Activity of Myosin
V--
Fig. 7 shows the motility
activity of DHM5 and M5IQ2 at various calcium ion concentrations.
Consistent with the actin-activated ATPase activity, the motility
activity was completely inhibited at high Ca2+
concentrations. An important finding is that the inhibition of motility
was achieved at much lower Ca2+ concentrations than the
inhibition of the ATPase activity. Furthermore, in contrast to its
effects on the inhibition of ATPase activity, addition of exogenous
calmodulin did not reverse the motility inhibition (Fig. 7,
C and D). We added exogenous calmodulin up to 59 µM at pCa 4, but the motility activity was not
recovered in contrast to the ATPase activity. A similar result was also obtained at pCa 6. The recovery of motility inhibited at
high Ca2+ was only achieved by reducing Ca2+
concentration (Fig. 7, A and B).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Ca2+ and calmodulin dependence of
actin filament sliding velocity of myosin V constructs.
A, Ca2+ dependence of motility activity of DHM5;
B, Ca2+ dependence notility activity of M5IQ2.
The flow cells with myosin V constructs filled with pCa 6 buffer was refilled with pCa 7 buffer for restoration of the
motility. C and D show the effect of exogenous
calmodulin on the motility activity of DHM5 and M5IQ2, respectively.
Exogenous calmodulin failed to rescue the motility activity of myosin V
at pCa 4. The same result was also obtained at
pCa 6 condition. Actin filament motility was observed in 30 mM KCl, 1 mM MgCl2, 12 µM calmodulin, 20 mM MOPS, pH 7.0, 4.5 µg/ml glucose, 216 µg/ml glucose oxidase, 36 µg/ml catalase, and
2 mM ATP at 25 °C. Measurements were made with three
independent preparations, and 11-20 actin filaments were measured to
obtain an average velocity for preparation. All values are mean
velocity ± S.D. In the conditions where actin filaments were
moved, nearly all actin filaments observed moved continuously.
|
|
Inhibition of the Actin-activated ATPase Activity by ADP--
It
was quite recently shown that the ADP release step is the rate-limiting
step for the actin-activated ATPase cycle of truncated myosin V (22).
Therefore, ADP inhibition of the ATPase activity of myosin V and the
effect of Ca2+ on this inhibition were studied. As shown in
Fig. 8, ADP strongly inhibited the
actin-activated ATPase activity both in the presence and absence of
Ca2+. By using a KATP of 1.4 µM (22), a Ki of 1.47 µM
was obtained from the ADP dependence of the ATPase activity under EGTA
conditions, whereas a Ki of 1.80 µM
was found under pCa 4 conditions. This value was
significantly lower than for conventional myosins (23-24).
Interestingly, Ca2+ did not affect the ADP inhibition
indicating that the affinity of myosin V for ADP is not influenced by
Ca2+.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 8.
Inhibition of the actin-activated ATPase
activity by ADP. The ATPase activity was measured as described in
Fig. 3. A, ADP concentration dependence of the
actin-activated ATPase activity of M5IQ2. B, Dixon plots of
A. , pCa 4; , 1 mM EGTA.
|
|
 |
DISCUSSION |
Except for striated muscle myosin II, the biochemically well
characterized myosins have self-regulated motor function or contain regulatory components within the myosin molecule itself. The motor function of conventional myosin from vertebrate smooth muscle and
non-muscle tissues is regulated by the phosphorylation of its
regulatory light chain (25-27). Molluscan conventional myosin is
regulated by direct Ca2+ binding to the essential light
chain as supported by the regulatory light chain (28). Interestingly,
the regulation requires a two-headed structure and the involvement of
inter-head interaction in the regulatory mechanism (20, 29-30). Myosin
I regulation is the most well studied of the unconventional myosins
from vertebrates. These vertebrate myosin Is contain calmodulin as
their light chains, and Ca2+ binding to this calmodulin
light chain regulates their motor activity (8-13). These results raise
several questions concerning the regulation of myosin V. Does
Ca2+ regulate myosin V motor function? If so, does
calmodulin play a critical role in the regulation? Is the number of
calmodulins in the myosin V molecule important for the regulation?
Finally, is the two-headed structure critical for regulation? In this
study, we produced three different constructs of myosin V to address these questions concerning regulation, i.e. double-headed
myosin V, single-headed myosin V with complete IQ motifs, and
single-head myosin V with two IQ motifs.
It was reported that the essential light chain of conventional myosin
copurified with myosin V from chicken tissue (31) suggesting that it
participates as a subunit of myosin V. However, the essential light
chain was not found in a myosin V preparation from mouse. Moreover, it
was quite recently reported that myosin V expressed in Sf9 cells
that were coinfected with calmodulin and essential light chain contains
calmodulin exclusively and not the essential light chain (32).
Therefore, the myosin V variants produced in the present study that
have only calmodulin as light chains represent the likely subunit
composition of physiologically relevant myosin V.
Quite recently, double-headed and single-headed myosin V constructs
similar to those produced in the present study were reported (32). It
was reported that the double-headed myosin V was quite unstable and
degraded during cell culture by proteolysis at the IQ domain (32). In
contrast, we have not seen any significant degradation of our
double-headed myosin V sample. Although the difference is unclear,
since the degradation was found at the IQ domain it is likely that the
degradation occurred due to a lack of calmodulin binding there.
Consistent with this notion, the SHM5 isolated by Wang et
al. (31) increased in ATPase activity with exogenous calmodulin
even while in EGTA, suggesting that their SHM5 was not saturated with
calmodulin. The myosin V constructs in this study were not further
activated by exogenous calmodulin under EGTA conditions, suggesting
that the sites are saturated with bound calmodulin consistent with the
determined stoichiometry of the bound calmodulin.
All of these myosin V constructs, i.e. DHM5, SHM5, and
M5IQ2, showed the same pCa dependence in their
actin-activated ATPase activity. The activity was significantly reduced
above pCa 6. It can be concluded that this decrease in the
ATPase activity is due to the dissociation of calmodulin molecule from
the heavy chain because: 1) myosin V-bound calmodulin decreased at
pCa 5 and higher, and approximately 1 mol of calmodulin from
M5IQ2 or 1-2 mol of calmodulin from DHM5 and SHM5 were dissociated
from the heavy chain; and 2) the decrease in ATPase activity observed at pCa 5 and higher was completely reversed by addition of
exogenous calmodulin. Since Ca2+ binds to calmodulin within
this range of free Ca2+, the scenario would be that
Ca2+ binding to the calmodulin bound to myosin V decreases
the affinity of calmodulin for myosin V. However, since only 1 or 2 mol
of the bound calmodulin dissociates from myosin V, the apparent
decrease in affinity should be the site-specific. The nature of the
binding of the IQ peptide with calmodulin has been modeled (33). In the
absence of Ca2+, the N-terminal lobe of calmodulin adopts a
closed conformation, whereas the C-terminal lobe adopts a semi-open
conformation that interacts with the N-terminal side of the IQ peptide
via a number of H bonds. Upon Ca2+ binding, calmodulin
adopts the open conformation, thus the C-terminal lobe cannot bind to
the IQ peptide. While the interaction between apocalmodulin and the IQ
peptide may diminish, Ca2+/calmodulin may now bind in a
distinct manner to the IQ peptide since in general it retains the
amphipathic character also found in various calmodulin target peptides
(34). It is plausible, therefore, that the dissociation of calmodulin
at high Ca2+ occurs at specific IQ sites that do not allow
calmodulin to rebind at high Ca2+ presumably due to a lack
of amphipathic character. The present result suggests that 1-2 mol of
calmodulin are dissociated from myosin V at high Ca2+. One
such Ca2+-dependent site would be the second IQ
region, since M5IQ2 loses 1 mol of calmodulin at high Ca2+
but M5IQ1 does not. This result is consistent with the recent report
(14). Another possible site is the last IQ region, which is least
conserved and where the second consensus Arg that interacts via three H
bonds with the N-terminal lobe of calmodulin (according to the model
(33)) is replaced by Lys.
It is of interest to identify how Ca2+ decreases the
actin-activated ATPase activity. Actin binding of myosin V in the
presence of ATP was unchanged with Ca2+; therefore,
Ca2+ does not alter its affinity for F-actin. It was
reported quite recently (21) that the rate-limiting step of the
unregulated truncated myosin V construct, i.e. (M5IQ1), is
the ADP off step. We examined the effect of ADP on the inhibition of
the ATPase activity, but the apparent Ki value was
not influenced by Ca2+. Interestingly, an inhibition of
ATPase activity was observed at high, but not low, F-actin
concentration in the presence of Ca2+. For conventional
myosin it is known that the inhibition of ATPase activity by high
F-actin concentrations is due to the inhibition of the ATP hydrolysis
step by F-actin (35). Therefore, it is plausible that the inhibition of
the ATPase activity by Ca2+ for myosin V is due to an
inhibition of ATP hydrolysis step.
The inhibition of the actin-activated ATPase activity was completely
reversed by the presence of micromolar levels of calmodulin. Since a
concentration of free calmodulin of several micromolar is present in
cells, the inhibition of ATPase activity may not be operating in
vivo. An important finding is that the motility of myosin V (DHM5)
is completely abolished below pCa 6 where no apparent
dissociation of calmodulin takes place. Furthermore, addition of a high
concentration of exogenous calmodulin failed to rescue this inhibition
of motility. These results indicate that the inhibition of the motility
of myosin V is not due to dissociation of calmodulin from the heavy
chain. The inhibition occurs between pCa 7 and 6 where
cytoplasmic Ca2+ concentration is regulated in most cell
types; therefore, the observed inhibition is physiologically relevant.
Similar results were reported for mammalian myosin I (12, 13). Since
this range of Ca2+ concentrations corresponds to the high
affinity C-terminal sites of calmodulin, it is likely that
Ca2+ binding to the C-terminal lobe of calmodulin and
consequent conformational changes are responsible for the inhibition of
motility. Supporting this notion, it was shown that deletion of the
C-terminal Ca2+-binding sites abolishes inhibition of the
motility of myosin I (13).
Quite recently, it was reported that truncated myosin V containing 2 IQ
motifs showed motility activity even at high Ca2+ when high
exogenous calmodulin was present although the velocity of the motility
is reduced (14). At present the reason of this apparent discrepancy
between the present result and that by Trybus et al. (14) is
obscure. The loss of the motility at high Ca2+ was not due
to the denaturation of myosin V since the perfusion of the flow cell
with low Ca2+ buffer (pCa 7 or less) completely
restored the motility (Fig. 7). We examined various exogenous
calmodulin concentrations up to 59 µM that is 5 times
higher than that used by Trybus et al. (14); therefore, it
is unlikely that the loss of the motility is due to the unsaturation of
the bound calmodulin. Actually, the inhibition of the motility is
observed at pCa 6, where virtually no calmodulin is
dissociated from myosin V heavy chain. The present results suggest that
true regulation of motility could require two N-terminal IQ domains, in
which the conformational change of calmodulin, but not the physical
dissociation of calmodulin, would trigger the inhibition of motility.
There is an apparent de-coupling between the ATP hydrolysis cycle and
mechanical events at higher Ca2+. This is different from
the regulation of conventional myosins in which the regulatory domain
regulates both ATPase and mechanical activities (25-28). It is
plausible that the change in calmodulin conformation alters the
rigidity of the "lever arm" and thus decouples the chemical and
mechanical events. Alternatively, the conformational change of
calmodulin could alter the interaction between calmodulin and the
"converter" domain of myosin V, thus inhibiting motility.
The present results clearly indicate that the two-headed structure is
not critical for regulation of mechanoenzymatic activity of myosin V. This is distinct from the regulation of conventional myosin, in which
an interaction between the two heads is involved in the regulation
(20-21, 28-30). Mammalian myosin I, a single-headed unconventional
myosin having calmodulin as light chain subunits, has been shown to
have Ca2+ dependence similar to that shown for myosin V in
the present study (8-13). Therefore, it is plausible that there is a
common motor activity regulatory mechanism in unconventional myosins carrying calmodulin light chains. However, more detailed biophysical and biochemical information is required for further understanding of
the molecular mechanism.
 |
ACKNOWLEDGEMENTS |
We thank Dr. D. J. Schmidt (University
of Massachusetts) for reading the manuscript. We also thank Dr. H. D. White (Eastern Virginia Medical School) for comments. We thank Dr.
Nancy Jenkins for mouse myosin V cDNA.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants AR 41653, HL 60381, and GM 55834.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Physiology,
University of Massachusetts Medical School, 55 Lake Ave. North,
Worcester, MA 01655-0127. Tel.: 508-856-1954; Fax: 508-856-4600. E-mail: mitsuo.ikebe@umassmed.edu.
Published, JBC Papers in Press, August 16, 2000, DOI 10.1074/jbc.M003132200
2
M. Ikebe, unpublished observations.
 |
ABBREVIATIONS |
The abbreviation used is:
MOPS, 4-morpholinepropanesulfonic acid.
 |
REFERENCES |
| 1.
|
Cheney, R. E.,
and Mooseker, M. S.
(1992)
Curr. Opin. Cell Biol.
4,
27-35
|
| 2.
|
Cheney, R. E.,
Riley, M. A.,
and Mooseker, M. S.
(1993)
Cell Motil. Cytoskeleton
24,
215-223
|
| 3.
|
Goodson, H. V.,
and Spudich, J. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
659-663
|
| 4.
|
Mooseker, M. S.,
and Cheney, R. E.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
633-675
|
| 5.
|
Titus, M. A.
(1997)
Trends Cell Biol.
7,
119-123
|
| 6.
|
Espindola, E. M.,
Espreafico, E. M.,
Coelho, M. V.,
Martins, A. R.,
Costa, F. R. C.,
Mooseker, M. S.,
and Larson, R. E.
(1992)
J. Cell Biol.
118,
359-368
|
| 7.
|
Cheney, R. E.,
O'Shea, M. K.,
Heuser, J. E.,
Coelho, M. V.,
Wolenski, J. S.,
Espreafico, E. M.,
Forscher, P.,
Larson, R. E.,
and Mooseker, M. S.
(1993)
Cell
75,
13-23
|
| 8.
|
Collins, K.,
Sellers, J. R.,
and Matsudaira, P. T.
(1990)
J. Cell Biol.
110,
1137-1147
|
| 9.
|
Swanljung-Colling, H.,
and Colling, J. H.
(1991)
J. Biol. Chem.
266,
1312-1319
|
| 10.
|
Wolenski, J. S.,
Hayden, S. M.,
Forscher, P.,
and Mooseker, M. S.
(1993)
J. Cell Biol.
122,
613-621
|
| 11.
|
Barylko, B.,
Wagner, M. C.,
Reizes, O.,
and Albanesi, J. P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
90,
490-494
|
| 12.
|
Zhu, T.,
and Ikebe, M.
(1996)
Biochemistry
35,
513-522
|
| 13.
|
Zhu, T.,
Beckingham, K.,
and Ikebe, M.
(1998)
J. Biol. Chem.
273,
20481-20486
|
| 14.
|
Trybus, K. M.,
Kremensova, E.,
and Freyzon, Y.
(1999)
J. Biol. Chem.
274,
27448-27456
|
| 15.
|
Spudich, J. A.,
and Watt, J.
(1971)
J. Biol. Chem.
246,
4866-4871
|
| 16.
|
Chien, Y.,
and Dawid, I.
(1984)
Mol. Cell. Biol.
4,
507-513
|
| 17.
|
Ikebe, M.,
Kambara, T.,
Stafford, W. F.,
Sata, M.,
Katayama, E.,
and Ikebe, R.
(1998)
J. Biol. Chem.
273,
17702-17707
|
| 18.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 19.
|
Ikebe, M.,
and Hartshorne, D. J.
(1985)
J. Biol. Chem.
260,
13146-13153
|
| 20.
|
Sata, M.,
Matsuura, M.,
and Ikebe, M.
(1996)
Biochemistry
35,
11113-11118
|
| 21.
|
Li, X.-D.,
Saito, J.,
Ikebe, R.,
Mabuchi, K.,
and Ikebe, M.
(2000)
Biochemistry
39,
2254-2260
|
| 22.
|
DeLa Cruz, E. M.,
Wells, A. L.,
Rosenfeld, S. S.,
Ostap, E. M.,
and Sweeney, H. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13726-13731
|
| 23.
|
White, H. D.,
Belknap, B.,
and Jiang, W.
(1993)
J. Biol. Chem.
268,
10039-10045
|
| 24.
|
White, H. D.,
Belknap, B.,
and Webb, M. R.
(1997)
Biochemistry
36,
11828-11836
|
| 25.
|
Hartshorne, D. J.
(1987)
in
Physiology of the Gastrointestinal Tract
(Johnson, L. R., ed), 2nd Ed.
, pp. 423-482, Raven Press, Ltd., New York
|
| 26.
|
Sellers, J. R.,
and Adelstein, R. S.
(1987)
Enzymes
18,
381-418
|
| 27.
|
Tan, J. L.,
Ravid, S.,
and Spudich, J. A.
(1992)
Annu. Rev. Biochem.
61,
721-759
|
| 28.
|
Xie, X.,
Harrison, D. H.,
Schlichting, I.,
Sweet, R. M.,
Kalabokis, V. N.,
Szent-Gyorgyi, A. G.,
and Cohen, C.
(1995)
Nature
368,
306-312
|
| 29.
|
Cremo, C. R.,
Sellers, J. R.,
and Facemyer, K. C.
(1995)
J. Biol. Chem.
270,
2171-2175
|
| 30.
|
Matsuura, M.,
and Ikebe, M.
(1995)
FEBS Lett.
363,
246-250
|
| 31.
|
Espindola, F. S.,
Cheney, R. E.,
Kings, S. M.,
Suter, D. M.,
and Moosekar, M. S.
(1996)
Mol. Biol. Cell
7,
372
|
| 32.
|
Wang, F.,
Chen, L.,
Arcucci, O.,
Harvey, E. V.,
Bowers, B.,
Yuhui, X.,
Hammer, J. A., III,
and Sellers, J. R.
(2000)
J. Biol. Chem.
275,
4329-4335
|
| 33.
|
Houdusse, A.,
Silver, M.,
and Cohen, C.
(1996)
Structure
4,
1475-1490
|
| 34.
|
Ikura, M.,
Clore, G. M.,
Gronenborn, A. M.,
Zhu, G.,
Kle, C. B.,
and Bax, A.
(1992)
Science
256,
632-638
|
| 35.
|
Meador, W. E.,
Means, A. R.,
and Quiochu, F. A.
(1992)
Science
257,
1251-1254
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Takagi, Y. Yang, I. Fujiwara, D. Jacobs, R. E. Cheney, J. R. Sellers, and M. Kovacs
Human Myosin Vc Is a Low Duty Ratio, Nonprocessive Molecular Motor
J. Biol. Chem.,
March 28, 2008;
283(13):
8527 - 8537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-d. Li, H. S. Jung, Q. Wang, R. Ikebe, R. Craig, and M. Ikebe
The globular tail domain puts on the brake to stop the ATPase cycle of myosin Va
PNAS,
January 29, 2008;
105(4):
1140 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Komatsu and M. Ikebe
The Phosphorylation of Myosin II at the Ser1 and Ser2 Is Critical for Normal Platelet-derived Growth Factor induced Reorganization of Myosin Filaments
Mol. Biol. Cell,
December 1, 2007;
18(12):
5081 - 5090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakata, Y. Watanabe, J. Usukura, and I. Mabuchi
Characterization of Native Myosin VI Isolated from Sea Urchin Eggs
J. Biochem.,
October 1, 2007;
142(4):
481 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ito, M. Ikebe, T. Kashiyama, T. Mogami, T. Kon, and K. Yamamoto
Kinetic Mechanism of the Fastest Motor Protein, Chara Myosin
J. Biol. Chem.,
July 6, 2007;
282(27):
19534 - 19545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Frank, S. R. Martin, B. N. T. Gruender, Y.-S. R. Lee, R. A. Simonette, P. M. Bayley, K. G. Miller, and K. M. Beckingham
Androcam Is a Tissue-specific Light Chain for Myosin VI in the Drosophila Testis
J. Biol. Chem.,
August 25, 2006;
281(34):
24728 - 24736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-d. Li, H. S. Jung, K. Mabuchi, R. Craig, and M. Ikebe
The Globular Tail Domain of Myosin Va Functions as an Inhibitor of the Myosin Va Motor
J. Biol. Chem.,
August 4, 2006;
281(31):
21789 - 21798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Debreczeni, L. Farkas, V. Harmat, C. Hetenyi, I. Hajdu, P. Zavodszky, K. Kohama, and L. Nyitray
Structural Evidence for Non-canonical Binding of Ca2+ to a Canonical EF-hand of a Conventional Myosin
J. Biol. Chem.,
December 16, 2005;
280(50):
41458 - 41464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Watanabe, K. Nomura, A. Ohyama, R. Ishikawa, Y. Komiya, K. Hosaka, E. Yamauchi, H. Taniguchi, N. Sasakawa, K. Kumakura, et al.
Myosin-Va Regulates Exocytosis through the Submicromolar Ca2+-dependent Binding of Syntaxin-1A
Mol. Biol. Cell,
October 1, 2005;
16(10):
4519 - 4530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Terrak, G. Rebowski, R. C. Lu, Z. Grabarek, and R. Dominguez
Structure of the light chain-binding domain of myosin V
PNAS,
September 6, 2005;
102(36):
12718 - 12723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-d. Li, R. Ikebe, and M. Ikebe
Activation of Myosin Va Function by Melanophilin, a Specific Docking Partner of Myosin Va
J. Biol. Chem.,
May 6, 2005;
280(18):
17815 - 17822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sato, H. D. White, A. Inoue, B. Belknap, R. Ikebe, and M. Ikebe
Human Deafness Mutation of Myosin VI (C442Y) Accelerates the ADP Dissociation Rate
J. Biol. Chem.,
July 9, 2004;
279(28):
28844 - 28854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Krementsov, E. B. Krementsova, and K. M. Trybus
Myosin V: regulation by calcium, calmodulin, and the tail domain
J. Cell Biol.,
March 15, 2004;
164(6):
877 - 886.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|